Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK | Market Cap | 23.42B |
| Revenue (ttm) | 6.04B |
| Net Income (ttm) | 609.00M |
| Shares Out | 266.17M |
| EPS (ttm) | 2.28 |
| PE Ratio | 38.60 |
| Forward PE | 35.02 |
| Dividend | 0.41 (0.47%) |
| Ex-Dividend Date | Dec 4, 2025 |
| Volume | 488,048 |
| Average Volume | 679,953 |
| Open | 88.15 |
| Previous Close | 88.60 |
| Day's Range | 87.60 - 88.35 |
| 52-Week Range | 80.10 - 143.90 |
| Beta | 1.55 |
| RSI | 49.97 |
| Earnings Date | Feb 4, 2026 |
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also prov... [Read more]
Financial Performance
In 2025, Ambu A/S's revenue was 6.04 billion, an increase of 11.98% compared to the previous year's 5.39 billion. Earnings were 609.00 million, an increase of 159.15%.
Financial StatementsNews
Ambu A/S Annual Shareholders Meeting Transcript
Ambu A/S Annual Shareholders Meeting Transcript
Ambu A/S (AMBBY) Shareholder/Analyst Call Prepared Remarks Transcript
Elastomeric Infusion Pumps Market worth $1.49 billion by 2030, at a CAGR of 5.3%, says MarketsandMarkets™
Delray Beach, FL, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Elastomeric Infusion Pumps Market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the fore...
Ambu AS (AMBFF) Q4 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges
Ambu AS (AMBFF) Q4 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges
Q4 2025 Ambu A/S Earnings Call Transcript
Q4 2025 Ambu A/S Earnings Call Transcript
Ambu A/S (AMBBY) Q4 2025 Earnings Call Transcript
Ambu A/S 2025 Q4 - Results - Earnings Call Presentation
Q3 2025 Ambu A/S Earnings Call Transcript
Q3 2025 Ambu A/S Earnings Call Transcript
Ambu A/S (AMBBY) Analyst/Investor Day - Slideshow
Ambu AS (AMBFF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
Ambu AS (AMBFF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
Ambu A/S goes ex dividend tomorrow
Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript
Ambu A/S reports 2023/24 financial year results
Ambu A/S 2024 Q4 - Results - Earnings Call Presentation
Ambu A/S (AMBFF) Q3 2024 Earnings Call Transcript Highlights: Strong Organic Growth and ...
Ambu A/S (AMBFF) Q3 2024 Earnings Call Transcript Highlights: Strong Organic Growth and Strategic Investments
Ambu A/S (AMBFF) Q2 2024 Earnings Call Transcript
Ambu A/S (OTCPK:AMBFF) Q2 2024 Results Conference Call May 14, 2024 5:00 AM ET Company Participants Britt Meelby Jensen - CEO Henrik Bender - CFO Conference Call Participants Martin Brenoe - Nordea Ch...
Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript
Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript
ANNUAL REPORT 2022/23 (EARNINGS RELEASE)
For the full 2022/23 financial year, Ambu reported 7.6% organic revenue growth. This was driven by Endoscope Solutions posting 15% organic growth, the main drivers being urology and ENT growing high d...
Ambu A/S (AMBFF) Q2 2023 Earnings Call Transcript
Ambu A/S (OTCPK:AMBFF) Q2 2023 Results Earnings Conference Call May 3, 2023 3:00 AM ET Company Participants Britt Meelby Jensen - Chief Executive Officer Thomas Frederik Schmidt - Executive Vice Presi...
Ambu A/S (AMBFF) Q1 2023 Earnings Call Transcript
Company Participants Britt Jensen - Chief Executive Officer Thomas Schmidt - Executive Vice President & Chief Financial Officer Conference Call Participants Christian Ryom - Danske Bank Rickard Anderk...
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S...
Ambu A/S (AMBFF) Q4 2022 Earnings Call Transcript
Ambu A/S (OTCPK:AMBFF) Q4 2022 Earnings Conference Call November 15, 2022 2:00 AM ET Company Participants Britt Meelby Jensen - Chief Executive Officer Thomas Schmidt - Executive Vice President & Chie...